Glioma: Types, Symptoms, and Treatments

Gliomas are a complex category of brain tumors originating from glial cells, which are the supportive cells in the central nervous system. Their multifaceted nature necessitates a comprehensive understanding of their types, symptoms, and treatment modalities to effectively manage this challenging condition.

What is Glioma?

Gliomas are a heterogeneous group of neoplasms arising from glial cells, including astrocytes, oligodendrocytes, and ependymal cells. These tumours can be classified based on their cell of origin and histological features, impacting both the clinical presentation and management strategies.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Types of Gliomas

Astrocytomas

Astrocytomas are the most prevalent type of glioma, originating from star-shaped glial cells known as astrocytes. They are further categorized into grades based on their malignancy:

Pilocytic Astrocytoma (Grade I): Typically benign and slow-growing, often occurring in children and young adults.
Diffuse Astrocytoma (Grade II): Infiltrative with a higher potential for progression.
Anaplastic Astrocytoma (Grade III): Malignant, with aggressive behaviour.
Glioblastoma Multiforme (Grade IV): Highly aggressive, representing the most common and deadliest primary brain tumour in adults.

Oligodendrogliomas

Originating from oligodendrocytes, these tumors often present as slow-growing masses and are classified into:

Oligodendroglioma (Grade II): Generally slow-growing with a better prognosis compared to astrocytomas.
Anaplastic Oligodendroglioma (Grade III): More aggressive with a higher malignancy grade.

Ependymomas

Ependymomas arise from ependymal cells lining the ventricular system and are classified into:

Subependymoma (Grade I): Slow-growing and typically benign.
Ependymoma (Grade II): Moderate growth rate.
Anaplastic Ependymoma (Grade III): Malignant and aggressive.

Symptoms of Glioma

The clinical presentation of gliomas varies depending on the tumour's location, size, and growth rate. Common symptoms include:

Neurological Deficits

Headaches: Often persistent and worsening over time.
Seizures: Particularly common in low-grade gliomas.
Cognitive and Personality Changes: Including memory loss, confusion, and mood swings.
Motor and Sensory Loss: Weakness or numbness, typically unilateral.

Raised Intracranial Pressure

Nausea and Vomiting: Often associated with morning headaches.
Vision Problems: Including double vision or loss of peripheral vision.

Diagnosing Glioma

Accurate diagnosis of glioma involves a combination of clinical evaluation, imaging studies, and histopathological analysis.

Imaging Techniques

Magnetic Resonance Imaging (MRI) is the gold standard for glioma evaluation, providing detailed images of the brain structure and tumour characteristics. Advanced imaging techniques such as MR spectroscopy and functional MRI can further delineate tumour metabolism and functional impacts.

Histopathological Examination

A biopsy, often performed stereotactically, is crucial for definitive diagnosis and grading of gliomas. Molecular profiling, including the assessment of IDH mutation status and 1p/19q co-deletion, provides additional prognostic information and guides treatment decisions.

Causes and Risk Factors

The aetiology of gliomas remains largely elusive, although several genetic and environmental factors have been implicated.

Genetic Predispositions

Inherited Syndromes: Conditions such as Neurofibromatosis Type 1, Li-Fraumeni syndrome, and Turcot syndrome increase glioma risk.
Genetic Mutations: Mutations in genes like IDH1, IDH2, and TP53 are common in gliomas.

Environmental Factors

Radiation Exposure: Therapeutic or occupational radiation exposure is a well-documented risk factor.
Lifestyle Factors: Limited evidence suggests possible links to lifestyle factors, although data remains inconclusive.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Treatment Modalities

Effective management of glioma involves a multidisciplinary approach integrating surgery, radiation therapy, and chemotherapy.

Surgical Intervention

The primary objective of surgery is maximal safe resection of the tumour, balancing tumour removal with preservation of neurological function. Surgical techniques such as awake craniotomy and intraoperative imaging enhance resection outcomes.

Radiation Therapy

Radiotherapy is a cornerstone of glioma treatment, particularly for high-grade tumours. Techniques such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery offer targeted treatment with minimal collateral damage.

Chemotherapy

Chemotherapeutic agents like temozolomide are standard in the treatment of high-grade gliomas, often administered concomitantly with radiotherapy. Novel therapies, including targeted agents and immunotherapies, are under investigation in clinical trials, offering hope for improved outcomes.

Prognosis and Follow-Up

The prognosis of glioma depends on tumour type, grade, molecular characteristics, and patient factors such as age and performance status. Regular follow-up with imaging studies is critical for monitoring disease progression and managing complications.

Prognostic Factors

Tumor Grade and Type: Higher grades are associated with poorer outcomes.
Molecular Markers: The presence of IDH mutations and 1p/19q co-deletion are favourable prognostic indicators.

Find Our Specialists

Book Doctor Appointment